1. Daugėlaitė G, Užkuraitytė K, Jagelavičienė E, Filipauskas A. Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis. Medicina(Kaunas). 2019;55(2):25.
https://doi.org/10.3390/medicina55020025
PMid:30678228 PMCid:PMC6410239

2. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME,Ranna V, Bossi P. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020; 126(19): 4423-31.
https://doi.org/10.1002/cncr.33100
PMid:32786044 PMCid:PMC7540329

3. Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, Strano S. Oral mucositis: The hidden side of cancer therapy. J Exp Clin Cancer Res.2020;39(1): 210.
https://doi.org/10.1186/s13046-020-01715-7
PMid:33028357 PMCid:PMC7542970

4. Khurana H, Pandey R, Saksena A, Kumar A. An evaluation of vitamin E and pycnogenol in children suffering from oral mucositis during cancer chemotherapy. Oral Dis. 2013; 19(5): 456-64.
https://doi.org/10.1111/odi.12024
PMid:23078515

5. Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S, Worthington HV. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev.2010; 2010(8):CD001973.
https://doi.org/10.1002/14651858.CD001973.pub4
PMid:20687070

6. Mohd Zaffarin AS, Ng S, Ng MH, Hassan H, Alias E. Pharmacology and pharmacokinetics of vitamin E: Nanoformulations to enhance bioavailability. Int J Nanomedicine.2020;15:9961-9974.
https://doi.org/10.2147/IJN.S276355
PMid:33324057 PMCid:PMC7733471

7. Liang L, Qiu L. Vitamin E succinate with multiple functions: A versatile agent in nanomedicine-based cancer therapy and its delivery strategies. Int J Pharm. 2021; 600:1204.
https://doi.org/10.1016/j.ijpharm.2021.120457
PMid:33676991

8. Lee GY, Han SN. The role of vitamin E in immunity. Nutrients. 2018; 10 (11):1614.
https://doi.org/10.3390/nu10111614
PMid:30388871 PMCid:PMC6266234

9. Nosratzehi T. Oral lichen planus: An overview of potential risk factors, biomarkers and treatments. Asian Pac J Cancer Prev.2018;19(5):1161-1167.
https://doi.org/10.22034/APJCP.2018.19.5.1161
PMid:29801395

10. Konuk Sener D, Aydin M, Cangur S, Guven E. The effect of oral care with chlorhexidine, vitamin E and honey on mucositis in pediatric intensive care patients: A randomized controlled trial. J Pediatr Nurs.2019; 45:e95-e101.
https://doi.org/10.1016/j.pedn.2019.02.001
PMid:30745073

11. Raza A, Karimyan N, Watters A , Emperumal CP., Al-Eryani K, Enciso R. Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: A systematic review and meta-analyses. Support Care Cancer.2022; 30(11), 8689-8703.
https://doi.org/10.1007/s00520-022-07190-4
PMid:35680672

12. Alterio D, Jereczek-Fossa BA, Fiore MR, Piperno G, Ansarin M, Orecchia R. Cancer treatment-induced oral mucositis. Anticancer Res.2007; 27(2), 1105-25.
PMid:17465250

13. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Lesley S, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp O, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med.2018;169(7), 467-73.
https://doi.org/10.7326/M18-0850
PMid:30178033

14. Wells G, Shea B, O'Connell D, Robertson J, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. 2014.

15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials.1996; 17(1): 1-12.
https://doi.org/10.1016/0197-2456(95)00134-4
PMid:8721797 PMCid:PMC10777702

16. Page JM, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ.2021;372:n71.
https://doi.org/10.1136/bmj.n71
PMid:33782057 PMCid:PMC8005924

17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics.1977; 33(1):159-74.
https://doi.org/10.2307/2529310
PMid:843571

18. El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent.2007; 31(3):167-70.
https://doi.org/10.17796/jcpd.31.3.r8371x45m42l10j7
PMid:17550040

19. Wadleigh RG, Redman RS, Graham ML, Krasnow SH, Anderson A, Cohen M. H. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med.1992;92(5):481-4.
https://doi.org/10.1016/0002-9343(92)90744-V
PMid:1580295

20. Solduzian M, Babaei MH, Goodarzi N, Honarmand H, Shabanir N. Effects of topical vitamin E mouthwash in preventing oral mucositis in allo genic hematopoietic stem cell transplant patients: A double-blind, placebo-controlled trial. IJBC.2021;13(3), 92-97.

21. Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, Feldman BM. Serial controlled N -of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer.2007; 43(8), 1269-75.
https://doi.org/10.1016/j.ejca.2007.02.001
PMid:17383174

22. Ferreira PR, Fleck JF, Diehl A, Barletta D, Braga-Filho A, Barletta A,Ilha L. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial. Head Neck.2004 ;26(4), 313-21.
https://doi.org/10.1002/hed.10382
PMid:15054734

23. Curra M, Gabriel A F, Ferreira MBC, Martins MAT, Brunetto AT, Gregianin LJ, Martins MD. Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy. Support Care Cancer.2021; 29(11), 6243-51.
https://doi.org/10.1007/s00520-021-06199-5
PMid:33846825

24. Pico J, Avila-Garavito A, Naccache P. Mucositis: Its occurrence, consequences, and treatment in the oncology setting. Oncologist.1998; 3(6): 446-51.
https://doi.org/10.1634/theoncologist.3-6-446
PMid:10388137

25. Lopez-Castano F, Onate-Sanchez RE, Roldan-Chicano R, Cabrerizo-Merino M. C. Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review. Med Oral Patol Oral Cir Bucal.2005;10(5): 412-21.

26. Docimo R, Anastasio MD, Bensi C. Chemotherapy-induced oral mucositis in children and adolescents: A systematic review. Eur Arch Paediatr Dent.2022; 23(4): 501-11.
https://doi.org/10.1007/s40368-022-00727-5
PMid:35779225

27. International Agency for Research on Cancer. (2022a). Globocan. [Consulted 05.2025] Retrieved from https://gco.iarc.fr/today/en/dataviz/tables?mode=population&sexes=2&cancers=34&age_start=1&age_end=3

28. International Agency for Research on Cancer. (2022b). Globocan. [Consulted 05.2025] Retrieved from https://gco.iarc.fr/today/en/dataviz/tables?mode=population&sexes=2&cancers=36&age_start=1&age_end=3

29. International Agency for Research on Cancer. (2022c). Globocan. [Consulted 05.2025] Retrieved from https://gco.iarc.fr/today/en/dataviz/pie?mode=population&group_populations=0&sexes=1&cancers=1&populations=903_904_905_908_909_935

30. Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, Kouloulias V. (2011). Oral squamous cell cancer: Early detection and the role of alcohol and smoking. Head Neck Oncol.2011; 3: 2.
https://doi.org/10.1186/1758-3284-3-2
PMid:21211041 PMCid:PMC3022893

31. International Agency for Research on Cancer. (2022d). Globocan. [Consulted 05.2025] Retrieved from https://gco.iarc.who.int/causes/alcohol/tools-pie?mode=2&sex=2&population=900&population_group=4&continent=0&country=0&cancer=40&key=attr_cases&lock_scale=0&pie_mode=1&is_donut=0&nb_results=6&age_group=3&group_colorectum=1

32. Banjar A, Patel V, Abed H. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: A scoping review. Oral Dis.2023;29(1), 29-39.
https://doi.org/10.1111/odi.14058
PMid:34695271

33. Ghoreishi Z, Shidfar F, Iravani M, Esfahani A, Ghavamzadeh A. Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation. Asia Pac J Clin Oncol.2007; 3(3), 113-18.
https://doi.org/10.1111/j.1743-7563.2007.00111.x

34. Nishimura N, Nakano K, Ueda K, Kodaira M, Yamada S, Mishima Y, Yokoyama M, Terui Y, Takahashi S, Hatake K. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas. Support Care Cancer.2012; 20(9): 2053-59.
https://doi.org/10.1007/s00520-011-1314-6
PMid:22116139

35. Saito Y, Takekuma Y, Takeshita T, Oshino T, Sugawara M. (2022). Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment. Sci Rep.2022;12(1):12587.
https://doi.org/10.1038/s41598-022-16935-4
PMid:35869165 PMCid:PMC9307799

36. Saito Y, Takekuma Y, Takeshita T, Oshino T, Sugawara M. Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer. Sci Rep.2023;13(1): 10169.
https://doi.org/10.1038/s41598-023-37285-9
PMid:37349388 PMCid:PMC10287713

37. Hasheminasab FS, Hashemi SM, Dehghan A, Sharififar F, Setayesh M, Sasanpour P, Tasbandi M, Raeiszadeh M. Effects of a plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial. J Integr Med.2020; 18(3):214-21.
https://doi.org/10.1016/j.joim.2020.02.008
PMid:32268991